Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
0(0%)
Results Posted
50%(3 trials)
Terminated
1(13%)

Phase Distribution

Ph phase_2
3
38%
Ph phase_1
5
63%

Phase Distribution

5

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
5(62.5%)
Phase 2Efficacy & side effects
3(37.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(6)
Terminated(2)

Detailed Status

Completed6
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
85.7%
Most Advanced
Phase 2

Trials by Phase

Phase 15 (62.5%)
Phase 23 (37.5%)

Trials by Status

withdrawn113%
completed675%
terminated113%

Recent Activity

0 active trials
Showing 5 of 8
completedphase_1

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Repeat Doses of PF-06372865 in Healthy Subjects

NCT03351751
completedphase_2

PF-06372865 in Subjects With Photosensitive Epilepsy

NCT02564029
withdrawnphase_1

An Open-label, Two-period, Fixed-sequence Study to Evaluate Multiple-dose Itraconazole Effect on The Single-dose PK of PF-06372865 in Healthy Subjects

NCT02475746
terminatedphase_2

POC Study in Partially Responsive Generalized Anxiety Disorder

NCT02310568
completedphase_2

PF-06372865 In Subjects With Chronic Low Back Pain

NCT02262754
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT03351751Phase 1

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Repeat Doses of PF-06372865 in Healthy Subjects

Completed
NCT02564029Phase 2

PF-06372865 in Subjects With Photosensitive Epilepsy

Completed
NCT02475746Phase 1

An Open-label, Two-period, Fixed-sequence Study to Evaluate Multiple-dose Itraconazole Effect on The Single-dose PK of PF-06372865 in Healthy Subjects

Withdrawn
NCT02310568Phase 2

POC Study in Partially Responsive Generalized Anxiety Disorder

Terminated
NCT02262754Phase 2

PF-06372865 In Subjects With Chronic Low Back Pain

Completed
NCT02217787Phase 1

Food Effect Study for PF-06372865

Completed
NCT02138500Phase 1

A Study to Examine the Distribution of PF-06372865 in the Brain of Healthy Volunteers Using Positron Emission Tomography and a Radioactive Tracer Following Oral Administration of One Dose of PF-06372865

Completed
NCT02070289Phase 1

A Study to Evaluate Safety, Toleration and Time Course of Plasma Concentration of Multiple Oral Doses of PF-06372865 in Healthy Subjects of Two AgeGroups, Aged 18-55 Years (Group 1) and Aged 56-75 Years (Group 2)

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8